Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

Abstract Title:

Effects of vitamin D supplementation on HbA1c and fasting glucose in hypertensive patients - a randomized controlled trial.

Abstract Source:

Diabetes Obes Metab. 2016 Jun 23. Epub 2016 Jun 23. PMID: 27334070

Abstract Author(s):

Martin R Grübler, Martin Gaksch, Katharina Kienreich, Nicolas Verheyen, Johannes Schmid, Bríain Ó Hartaigh, Georg Richtig, Hubert Scharnagl, Andreas Meinitzer, Astrid Fahrleitner-Pammer, Winfried März, Andreas Tomaschitz, Stefan Pilz

Article Affiliation:

Martin R Grübler

Abstract:

BACKGROUND: Experimental data have indicated that vitamin D insufficiency has an important influence on glucose metabolism. The majority of epidemiological studies have demonstrated an association between low vitamin D and insulin resistance and/or type 2 diabetes mellitus. Nevertheless evidence from randomized controlled trials remains inconclusive.

OBJECTIVE: To investigate the efficacy of vitamin D supplementation on glycaemic control.

DESIGN: The Styrian Vitamin D Hypertension Trial is a single-centre, double-blind, placebo-controlled study conducted between 2011 and 2014 at the Medical University of Graz, Austria. We enrolled 200 persons with arterial hypertension and 25-hydroxyvitamin D (25(OH)D) concentrations below 30 ng/mL. Study participants were randomized to receive either 2800 IU of vitamin D or placebo per day for 8 weeks. The present investigation is a post-hoc analysis that incorporated analysis of covariance (ANCOVA) approach while adjusting for baseline differences.

RESULTS: A total of 185 participants (mean±SD age, 60.1 ± 11.3 years; 47% women; mean 25-hydroxyvitamin D, 21.2 ± 5.6 ng/mL, mean HbA1c 44.8 ± 11.8 mmol/mol and mean BMI 30.4 ± 5.4 kg/m(2) ) completed the trial. ANCOVA revealed a mean treatment effect (95% confidence interval) on HbA1c of -3.52 mmol/mol (95%CI-6.7 to -0.34; P = 0.045). There was no difference in fasting glucose -4.7 mg/dL (95%CI -16.3 to 6.9; P = 0.426).

CONCLUSIONS: Vitamin D supplementation in obese hypertensive patients with low 25-hydroxyvitamin D reduces HbA1c. This finding warrants further investigations on potential vitamin D effects on glucose homeostasis.

Study Type : Human Study

Print Options


Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2019 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.